{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:52Z","timestamp":1788480532659,"version":"build-2803163510"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1759,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We documented the midterm prognosis of left ventricular thrombus (LVT) in heart failure (HF) patients with dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM). We aimed to characterize patients with LVT in the context of HF with reduced (\u226440%) left ventricular ejection fraction and evaluate their risk for death and\/or embolic events, overall, and specifically in patients with ischaemic or non-ischaemic aetiology. We also intended to identify risk factors for LVT in patients with DCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We included all HF patients (N = 105, age 56 \u00b1 13) admitted from 2005 to 2018 in our institution for LVT without significant valve disease\/prosthesis, heart transplant\/left ventricular assist device, congenital heart disease, or acute myocardial infarction. Our primary endpoint was the 1 year risk of the composite of all-cause mortality (ACM) and symptomatic embolic events. Mean left ventricular ejection fraction was 23 \u00b1 9%, and median BNP was 1795 pg\/mL. Most (97%) patients were treated with vitamin K anticoagulants, and 64% had ICM. Symptomatic embolic events and\/or ACM occurred in 20% of the population [embolic events (all within 30 days of LVT diagnosis) 15% and ACM 6%] and was similarly frequent in DCM or ICM (P &amp;gt; 0.05). Suspected\/transient embolic events were more frequent in DCM (overall 13%; 29% in DCM vs. 5% in ICM, P &amp;lt; 0.01). Major bleeding occurred in 5% of patients. Left ventricular reverse remodelling occurred in 65% of patients, more frequently in DCM (86% in DCM vs. 65% in ICM, P = 0.02). In a case\u2013control analysis matching DCM patients, BNP level was the only factor significantly associated with LVT (2447 pg\/mL in LVT vs. 347 pg\/mL, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with LVT have markedly high natriuretic peptides and experience a 20% 1 year risk for embolic events and\/or death following diagnosis despite anticoagulant treatment. Most patients have favourable remodelling\/recovery. As all symptomatic embolic events occurred within 30 days of LVT diagnosis, a very careful initial management is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13211","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T07:43:16Z","timestamp":1614238996000},"page":"1333-1341","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical Profile and Midterm Prognosis of Left Ventricular Thrombus in Heart Failure"],"prefix":"10.1093","volume":"8","author":[{"given":"Anne-Iris","family":"Lema\u00eetre","sequence":"first","affiliation":[{"name":"Bordeaux University Hospital (CHU) , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Picard","sequence":"additional","affiliation":[{"name":"Bordeaux University Hospital (CHU) , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Maurin","sequence":"additional","affiliation":[{"name":"Bordeaux University Hospital (CHU) , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Faure","sequence":"additional","affiliation":[{"name":"Bordeaux University Hospital (CHU) , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dos Santos","sequence":"additional","affiliation":[{"name":"Bordeaux University Hospital (CHU) , Bordeaux ,","place":["France"]},{"name":"Centre de Recherche Cardio-Thoracique de Bordeaux, Universit\u00e9 de Bordeaux , Bordeaux ,","place":["France"]},{"name":"IHU Liryc, Electrophysiology and Heart Modelling Institute, Foundation Bordeaux Universit\u00e9 , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques Plurith\u00e9matique 1433, Inserm U1116, CHRU Nancy, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"2026012115074152700_ehf213211-bib-0001","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026012115074152700_ehf213211-bib-0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5551\/jat.13540","article-title":"Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents","volume":"20","author":"Lee","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"2026012115074152700_ehf213211-bib-0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009723","article-title":"Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study","volume":"12","author":"Velangi","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012115074152700_ehf213211-bib-0004","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","article-title":"Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes","volume":"73","author":"McCarthy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012115074152700_ehf213211-bib-0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/eurjhf\/hfs171","article-title":"Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm","volume":"15","author":"Hopper","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012115074152700_ehf213211-bib-0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"key":"2026012115074152700_ehf213211-bib-0007","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2026012115074152700_ehf213211-bib-0008","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"2026012115074152700_ehf213211-bib-0009","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012115074152700_ehf213211-bib-0010","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012115074152700_ehf213211-bib-0011","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1093\/eurheartj\/ehz427","article-title":"A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial","volume":"40","author":"Mehra","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012115074152700_ehf213211-bib-0012","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0002-9149(83)90588-X","article-title":"Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography","volume":"52","author":"Gottdiener","year":"1983","journal-title":"Am J Cardiol"},{"key":"2026012115074152700_ehf213211-bib-0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/hrt.62.1.26","article-title":"Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy","volume":"62","author":"Ciaccheri","year":"1989","journal-title":"Br Heart J"},{"key":"2026012115074152700_ehf213211-bib-0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00043798-199504000-00003","article-title":"Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?","volume":"2","author":"Katz","year":"1995","journal-title":"J Cardiovasc Risk"},{"key":"2026012115074152700_ehf213211-bib-0015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/oxfordjournals.eurheartj.a015073","article-title":"Systemic thromboembolism in chronic heart failure: a prospective study in 406 patients","volume":"17","author":"Cioffi","year":"1996","journal-title":"Eur Heart J"},{"key":"2026012115074152700_ehf213211-bib-0016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2018.07.130","article-title":"Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure","volume":"274","author":"Popovic","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026012115074152700_ehf213211-bib-0017","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13211","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13211","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/2\/1333\/65926523\/eschf_8_2_1333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/2\/1333\/65926523\/eschf_8_2_1333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:09:37Z","timestamp":1769026177000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/2\/1333\/8381869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13211","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"2020-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}